References
-
1
Celermajer D S, Sorensen K E, Gooch V M, Spiegelhalter D J, Miller O I, Sullivan I D, Lloyd J K, Deanfield J E.
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.
Lancet.
1992;
340
1111-1115
-
2
Ebenbichler C F, Sturm W, Ganzer H, Bodner J, Mangweth B, Ritsch A, Sandhofer A, Lechleitner M, Foger B, Patsch J R.
Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids.
Atherosclerosis.
2001;
158
483-490
-
3
Herman S M, Robinson J T, McCredie R J, Adams M R, Boyer M J, Celermajer D S.
Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men.
Arterioscler Thromb Vasc Biol.
1997;
17
2004-2009
-
4
Kenny A M, Prestwood K M, Gruman C A, Fabregas G, Biskup B, Mansoor G.
Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels.
J Gerontol A Biol Sci Med Sci.
2002;
57
M460-465
-
5
Liu P Y, Wishart S M, Handelsman D J.
A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency.
J Clin Endocrinol Metab.
2002;
87
3125-3135
-
6
Ly L P, Jimenez M, Zhuang T N, Celermajer D S, Conway A J, Handelsman D J.
A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.
J Clin Endocrinol Metab.
2001;
86
4078-4088
-
7
McCredie R J, McCrohon J A, Turner L, Griffiths K A, Handelsman D J, Celermajer D S.
Vascular reactivity is impaired in genetic females taking high-dose androgens.
J Am Coll Cardiol.
1998;
32
1331-1335
-
8
Ong P J, Patrizi G, Chong W C, Webb C M, Hayward C S, Collins P.
Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease.
Am J Cardiol.
2000;
85
269-272
-
9
Penotti M, Sironi L, Cannata L, Vigano P, Casini A, Gabrielli L, Vignali M.
Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries.
Fertil Steril.
2001;
76
235-240
-
10
Sader M A, Celermajer D S.
Endothelial function, vascular reactivity and gender differences in the cardiovascular system.
Cardiovasc Res.
2002;
15
597-604
-
11
Thompson P D, Ahlberg A W, Moyna N M, Duncan B, Ferraro-Borgida M, White C M, McGill C C, Heller G V.
Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease.
Am Heart J.
2002;
143
249-256
-
12
Webb C M, McNeill J G, Hayward C S, de Zeigler D, Collins P.
Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease.
Circulation.
1999;
100
1690-1696
-
13
Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis S.
Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilatation in postmenopausal women already receiving estrogen.
J Clin Endocrinol Metab.
2001;
1
158-161
-
14
Wu F C, von Eckardstein A.
Androgens and coronary artery disease.
Endocr Rev.
2003;
24
183-217
-
15
Zitzmann M, Brune M, Kornmann B, Gromoll J, von Eckardstein S, von Eckardstein A, Nieschlag E.
The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity.
J Clin Endocrinol Metab.
2001;
86
4867-4873
-
16
Zitzmann M, Brune M, Nieschlag E.
Vascular reactivity in hypogonadal men is reduced by androgen substitution.
J Clin Endocrinol Metab.
2002;
87
5030-5037
Prof. Dr. FRCP E. Nieschlag
Institute of Reproductive Medicine of the University
Domagkstraße 11
48129 Münster
Germany
Phone: + 492518356097
Fax: + 49 25 18 35 60 93
Email: nieschl@uni-muenster.de
